Advertisement

Topics

Micromet, Inc. Company Profile

18:33 EST 18th November 2017 | BioPortfolio

Micromet, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibody-based therapies for the treatment of cancer. Its product development pipeline includes novel antibodies generated with its proprietary BiTE® technology, as well as conventional monoclonal antibodies. Two of Micromet's BiTE antibodies and three of its conventional antibodies are currently in clinical trials. Micromet has collaborations with a number of leading pharmaceutical and biotechnology companies, including sanofi-aventis, Bayer Schering Pharma, Merck Serono, Boehringer Ingelheim, MedImmune and Nycomed. Additional information can be found at www.micromet-inc.com.


News Articles [4 Associated News Articles listed on BioPortfolio]

Micromet: From Europe to the US: The Transformation of Micromet

In this interview, Fintan Walton talks to Christian Itin, President and CEO of antibody technology company Micromet. Christian talks about how the company was set up in Munich to address one of the ga...

R&D Deal, PTV News: May 06, 2010

Boehringer Ingelheim and Micromet collaborate on R&D and commercialisation of cancer therapy

News Headlines, PTV News: May 06, 2010

A look at today's forthcoming news stories: Merck & Co restructures deal with Ariad to take control of sarcoma therapy; Boehringer Ingelheim and Micromet to collaborate on R&D for multiple myeloma, an...

PTV News: Oct 29, 2009

Top stories on October 29th, 2009: Emerging markets and swine flu ramp GSK profits Sanofi's cancer deal with Micromet Vertex Hep C drug boasts impressive trial results Tysabri test for PML risk ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Micromet, Inc.

Micromet, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative antibody-based therapies for the treatment of cancer. Its product development pi...

Micromet Inc.

Micromet, Inc. (NASDAQ: MITI) is a transatlantic biopharmaceutical company formed through the mergerof Micromet AG and CancerVax, Inc. in May 2006.Focused on the development and design of novel antibo...

More Information about "Micromet, Inc." on BioPortfolio

We have published hundreds of Micromet, Inc. news stories on BioPortfolio along with dozens of Micromet, Inc. Clinical Trials and PubMed Articles about Micromet, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Micromet, Inc. Companies in our database. You can also find out about relevant Micromet, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Biopharmaceuticals
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...


Corporate Database Quicklinks



Searches Linking to this Company Record